Chinese Markets for Prostate Cancer Treatment Drugs : Market Research Report

Chinese Markets for Prostate Cancer Treatment Drugs

Published by: Asia Market Information & Development Company

Published: Feb. 1, 2009 - 204 Pages

I.INTRODUCTION: Report Scope and Methodology; Executive Summary
II.BUSINESS ENVIRONMENT: Economic Outlook; Key Economic Indicators; Industrial Output; Population and Labor; Foreign Investment; Foreign Trade; Financial and Tax Regulations; Banking System and Regulations; Foreign Exchange; Taxes, Tariff and Custom Duties
III.PROSTATE CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS: Prostate Cancer Treatment Drugs Industry Structure; Market Size; Market Growth Drivers; Prostate Cancer Treatment Drugs Sales Volume; Major Producer Facility Locations and Sales Volume; Market Share of Key Producers; Labor Cost; Potential Entrants; Major Distributors; Major Foreign Investments; Technology Development
IV. PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND: Overview; Demand of Prostate Cancer Treatment Drugs by Region in 2008; Prostate Cancer Treatment Drugs Sales Volume; Bicalutamide Sales volume and market share; Flutamide Sales volume and market share; Cyproterone Acetate Sales volume and market share; Megestrol Acetate Sales volume and market share; Triptorelin Acetate Sales volume and market share; Goserelin Acetate Sales volume and market share; Leuprorelin Acetate Sales volume and market share; Estramustine disodium phosphate Sales volume and market share; Docetaxel Sales volume and market share; Other Prostate Cancer Treatment Drugs Sales volume and market share; Prostate Cancer Treatment Drugs Imports; Pricing Trends
V. PROSTATE CANCER TREATMENT DRUGS MARKET OUTLOOK: Prostate Cancer Treatment Drugs Markets Outlook Overview; Government Regulations; Health Care Insurance Industry Overview; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
VI. MARKETING STRATEGIES: Distribution System in China; China's Distribution System; Prostate Cancer Treatment Drugs Distribution Channels; Transportation and Freight Infrastructure; Communications; Market Entry Channels; Exporting to China; Export Market Overview; Chinese Trading Practice; Chemical Trade Companies; Import Restrictions in China; Technology Licensing; Technology Licensing Overview; Intellectual Property Protection; Joint Venture; Joint Venture Overview; Advantages and Disadvantages; Wholly Owned Enterprises; Foreign Wholly Owned Enterprises Overview; Advantages and Disadvantages; Other Market Entry Channels; Setting up Sales Offices; Selling to China through Attending Trade Fairs; Contacting Chinese Companies; Advertising; Market Entry Strategies; Understanding Differences; Business Practice Differences; Knowledge of Regulations and Restrictions; Dealing with Governments
VII. PROSTATE CANCER TREATMENT DRUGS PRODUCER DIRECTORY: Prostate Cancer Treatment Drugs Producer Profiles; Distributors and Trading Companies; Research Institutions and Associations
LIST OF TABLES
I. INTRODUCTION: Economic Outlook Summary
II. BUSINESS ENVIRONMENT: Key Economic Indicators; Industrial Output; Population and Labor Force Trends; Foreign Investment and Loans; Foreign Trade
III.PROSTATE CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS: Prostate Cancer Treatment Drugs Sales Volume; Major Producer Facility Locations; Major Prostate Cancer Treatment Drugs Producer Sales Volume; Market Share of Key Producers; Major Foreign Investments
IV.PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND: Total Prostate Cancer Treatment Drugs Sales Volume; Prostate Cancer Treatment Drug Major Producer and Their Market Share; Chemotherapeutic Drug Major Producer and Their Market Share; Bicalutamide Major Producer and Their Market Share; Flutamide Major Producer and Their Market Share; Cyproterone Acetate Major Producer and Their Market Share; Megestrol Acetate Major Producer and Their Market Share; Luteinizing Hormone Releasing Hormonr Analogue Major Producer and Their Market Share; Triptorelin Major Producer and Their Market Share; Goserelin Acetate Major Producer and Their Market Share; Leuprorelin Acetate Major Producer and Their Market Share; Estramustine phosphate Major Producer and Their Market Share; Docetaxel Major Producer and Their Market Share; Prostate Cancer Treatment Drugs Import
V.PROSTATE CANCER TREATMENT DRUGS MARKET OUTLOOK: Consumer Spending Trend; Demographic Trends; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
LIST OF CHARTS
I. NTRODUCTION: Prostate Cancer Treatment Drugs Sales Volume
II. BUSINESS ENVIRONMENT: China's GDP and Industrial Output; Industrial Output by Ownership; China’s Imports and Exports
III.PROSTATE CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS: Prostate Cancer Treatment Drugs Sales Volume; Androgen Receptor Antagonist Sales Volume by Drugs Classification; Luteinizing Hormone Releasing Hormonr Analogue Sales Volume by Drugs Classification; Prostate Cancer Treatment Drugs Sales Volume
IV.PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND: Prostate Cancer Treatment Drugs Sales Volume; Worldwide Prostate Cancer Treatment Drugs Demand by region; Androgen Receptor Antagonist Sales Volume and Market Share; Androgen Receptor Antagonist Sales Volume by Drugs Classification; Bicalutamide Sales Volume and Market Share; Flutamide Sales Volume and Market Share; Cyproterone Acetate Sales Volume and Market Share; Megestrol Acetate Sales Volume and Market Share; Luteinizing Hormone Releasing Hormonr Analogue Sales Volume and Market Share; Luteinizing Hormone Releasing Hormonr Analogue Sales Volume by Drugs Classification; Triptorelin Sales Volume and Market Share; Goserelin Acetate Sales Volume and Market Share; Leuprorelin Acetate Sales Volume and Market Share; Estramustine phosphate Sales Volume and Market Share; Docetaxel Sales Volume and Market Share; Other Prostate Cancer Treatment Drugs Sales Volume and Market Share; Prostate Cancer Treatment Drugs Import Volume; Androgen Receptor Antagonist Import and Market Share; Androgen Receptor Antagonist Import by Drugs Classification; Bicalutamide Import Volume and Market Share; Flutamide Import Volume and Market Share; Cyproterone Acetate Import Volume and Market Share; Megestrol Acetate Import Volume and Market Share; Luteinizing Hormone Releasing Hormone Analogue Import Volume and Market Share; Luteinizing Hormone Releasing Hormone Analogue Import by Drugs Classification; Leuprorelin Acetate Import Volume and Market Share; Triptorelin Import Volume and Market Share; Goserelin Acetate Import Volume and Market Share; Estramustine phosphate Import Volume and Market Share; Docetaxel Import Volume and Market Share; Other Import Volume and Market Share
VI. MARKETING STRATEGIES: China’s Distribution Channel

Abstract

China's demand for Prostate Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

2/15/2012 - 31

Chinese Markets for Prostate Cancer Treatment Drugs

Table of Contents

Abstract